- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01203293
Cognitive Behavioral Therapy (CBT) for Latinos With Generalized Anxiety Disorder in the General Medical Sector
August 26, 2014 updated by: Mildred Vera, University of Puerto Rico
CBT for Latinos With Generalized Anxiety Disorder in the General Medical Sector
The purpose of this project is to implement culturally adapted Cognitive Behavioral Therapy (CBT) based interventions in general health settings that are delivered to reduce Generalized Anxiety Disorder (GAD) symptoms, increase levels of functioning, and improve health-related quality of life.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This project seeks to lay the foundation for an effectiveness trial that will lead to the advancement of CBT based treatments for GAD among Spanish-speaking Latinos, particularly Puerto Ricans.
This area of research is important in light of the limited treatment options currently available for Spanish-speakers with GAD and the long-term negative consequences of this condition.
Participants in this study are recruited in general health settings.
Patients meeting criteria for enrollment will be randomly assigned to receive either cognitive behavior based therapy or treatment as usual.
Assessments for all participants will be collected at baseline, post-treatment, and at two months follow-up visits.
Study Type
Interventional
Enrollment (Actual)
90
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
San Juan, Puerto Rico, 00936
- University of Puerto Rico, Medical Sciences Campus
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- diagnosis of GAD
- 18 to 65 years
- Spanish speaker
- able to read and write
- plan to continue receiving services in the health care setting during the next six months
Exclusion Criteria:
- severe cognitive impairment, psychoses, history of bipolar disease, alcohol or drug abuse or dependence
- clinically judged to have a high acute suicide risk
- life-threatening medical condition
- currently receiving psychotherapy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Treatment as usual
|
Treatment as usual is an active comparator group in which patients are provided referrals to specialty mental health care services or can use any primary or specialty care services available to them in usual care.
|
|
Experimental: Cognitive Behavior Therapy
|
15-20 individual psychotherapy sessions
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Penn State Worry Questionnaire
Time Frame: Baseline
|
Baseline
|
|
Penn State Worry Questionnaire
Time Frame: Week 20
|
Week 20
|
|
Penn State Worry Questionnaire
Time Frame: Week 28.
|
Week 28.
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
SF-36 Social Functioning Scale
Time Frame: Baseline
|
Baseline
|
|
SF-36 Social Functioning Scale
Time Frame: Week 20
|
Week 20
|
|
SF-36 Social Functioning Scale
Time Frame: Week 28
|
Week 28
|
|
Quality of Life Inventory
Time Frame: Baseline
|
Baseline
|
|
Quality of Life Inventory
Time Frame: Week 20
|
Week 20
|
|
Quality of Life Inventory
Time Frame: Week 28
|
Week 28
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2009
Primary Completion (Actual)
February 1, 2013
Study Completion (Actual)
February 1, 2013
Study Registration Dates
First Submitted
June 11, 2010
First Submitted That Met QC Criteria
September 15, 2010
First Posted (Estimate)
September 16, 2010
Study Record Updates
Last Update Posted (Estimate)
August 28, 2014
Last Update Submitted That Met QC Criteria
August 26, 2014
Last Verified
August 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 5SC1MH90599-2
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Generalized Anxiety Disorder
-
University of Southern CaliforniaNational Institute of Mental Health (NIMH)RecruitingGeneralized Anxiety Disorder (GAD)United States
-
Florida State UniversityRecruitingAnxiety | Generalized Anxiety Disorder (GAD) | WorryingUnited States
-
Wayne State UniversityNational Institute of Mental Health (NIMH)RecruitingAnxiety Disorders | Generalized Anxiety Disorder (GAD)United States
-
AbbVieRecruitingGeneralized Anxiety Disorder (GAD)United States, Puerto Rico
-
Texas Tech UniversityRecruitingGrief | Anxiety Disorder Generalized | Depression in AdultsUnited States
-
University of California, IrvineNational Center for Complementary and Integrative Health (NCCIH)Not yet recruitingMajor Depressive Disorder | Generalized Anxiety Disorder (GAD)
-
PsyScaleNot yet recruitingMajor Depressive Disorder (MDD) | Generalized Anxiety Disorder (GAD)
-
National Health Research Institutes, TaiwanNot yet recruitingMajor Depressive Disorder (MDD) | Generalized Anxiety Disorder (GAD)
-
Psicofarma, S.A. De C.V.Recruiting
-
Bout Me HealingCompletedSubstance Use Disorder (SUD) | Anxiety Disorder GeneralizedUnited States
Clinical Trials on Cognitive behavior based therapy
-
Stockholm UniversityKarolinska InstitutetCompleted
-
Qazvin University Of Medical SciencesUnknownInsomniaIran, Islamic Republic of
-
Örebro County CouncilKarolinska InstitutetCompleted
-
Karolinska InstitutetCompletedAtrial Fibrillation | ArrhythmiaSweden
-
Karolinska InstitutetCompleted
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationCompleted
-
US Department of Veterans AffairsCompleted
-
Lamar UniversityCompletedTinnitusUnited States
-
Karolinska InstitutetCompleted
-
Texas Tech UniversityRecruitingGrief | Mental Health Issue | Burden, CaregiverUnited States